The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to alzheimer's disease-associated neurodegeneration and oxidative stress

Journal of Neuroscience

Volumn 20, Issue 19, 2000, Pages 7345-7352

  Greeve, I ^a   Hermans Borgmeyer, I ^a   Brellinger, C ^a   Kasper, D ^a   Gomez Isla, T ^a   Behl, C ^a   Levkau, B ^a   Nitsch, R M ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer's disease; Differential display; Human DIMINUTO DWARF1 homolog; Neurodegeneration; Oxidative stress; Seladin 1; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; CASPASE 3; FLAVINE ADENINE NUCLEOTIDE; GENE PRODUCT; MESSENGER RNA; OXIDOREDUCTASE; PROTEIN SELEDIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CAENORHABDITIS ELEGANS; CELL LINE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; FRONTAL CORTEX; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NERVE DEGENERATION; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PARIETAL LOBE; PATHOGENESIS; PLANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TEMPORAL LOBE;

EID: 0034307463     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-19-07345.2000     Document Type: Article

References (42)

1. The Bcl-2 protein family: Arbiters of cell survival
2. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
3. Mitochondria, free radicals, and neurodegeneration
4. Hydrogen peroxide mediates amyloid beta protein toxicity
5. The tomato DWARF enzyme catalyses C-6 oxidation in brassinosteroid biosynthesis
6. Oxidative stress in Huntington's disease
7. Conversion of Bcl-2 to a Bax-like death effector by caspases
8. The Arabidopsis dwarf1 mutant is defective in the conversion of 24-methylenecholesterol to campesterol in brassinosteroid biosynthesis
9. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
10. A novel oxidoreductase family sharing a conserved FAD-binding domain
11. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease
12. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
13. The preparation of subcellular organelles from mouse liver in self-generated gradients of iodixanol
14. Distribution of somatostatin receptor subtype 1 mRNA in the developing cerebral hemispheres of the rat
15. A human brain L-3-hydroxyacylcoenzyme A dehydrogenase is identical to an amyloid beta-peptide-binding protein involved in Alzheimer's disease
16. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction
17. The Arabidopsis DIMINUTO/DWARF1 gene encodes a protein involved in steroid synthesis
18. Cleavage of p21Cipl/Waf1 and p27Kipl mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade
19. Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-kappa B loop
20. Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease
21. Recent developments in the field of plant steroid hormones
22. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I)
23. A putative FAD-binding domain in a distinct group of oxidases including a protein involved in plant development
24. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1
25. Binding of amyloid beta-peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): Regulation of an SDR enzyme activity with implications for apoptosis in Alzheimer's disease
26. Screening differentially expressed cDNA clones obtained by differential display using amplified RNA
27. Increased antioxidant enzyme activity in amyloid beta protein-resistant cells
28. Cellular mechanisms of resistance to chronic oxidative stress
29. Translating cell biology into therapeutic advances in Alzheimer's disease
30. A distinct ER/IC gamma-secretase competes with the proteasome for cleavage of APP
31. Expression of beta-amyloid precursor protein-CD3 gamma chimeras to demonstrate the selective generation of amyloid beta(1-40) and amyloid beta(1-42) peptides within secretory and endocytic compartments
32. The germ cell nuclear factor mGCNF is expressed in the developing nervous system
33. The DIMINUTO gene of Arabidopsis is involved in regulating cell elongation
34. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism
35. Amplified RNA synthesized from limited quantities of heterogeneous cDNA
36. Entorhinal cortex pathology in Alzheimer's disease
37. Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors
38. Identification of genes regulated by muscarinic acetylcholine receptors: Application of an improved and statistically comprehensive mRNA differential display technique
39. Presenilin 1 regulates the processing of betaamyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi
40. Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
41. Role of ERAB/L-3-hydroxyacyl-coenzyme A dehydrogenase type II activity in Aβ-induced cytotoxicity
42. Subcellular distribution and turnover of presenilins in transfected cells